China Universal Asset Management Company’s Ironwood Pharmaceuticals IRWD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$110K Sell
26,198
-2,738
-9% -$10.6K 0.01% 410
2026
Q1
$102K Buy
28,936
+2,428
+9% +$9.95K 0.01% 402
2025
Q4
$89.3K Sell
26,508
-1,964
-7% -$5.1K 0.01% 416
2025
Q3
$37.3K Sell
28,472
-4,029
-12% -$4.17K ﹤0.01% 447
2025
Q2
$23.3K Buy
32,501
+402
+1% +$316 ﹤0.01% 450
2025
Q1
$47.2K Sell
32,099
-1,833
-5% -$4.37K ﹤0.01% 422
2024
Q4
$150K Buy
33,932
+3,209
+10% +$13K 0.01% 351
2024
Q3
$127K Buy
30,723
+12,047
+65% +$64.8K 0.01% 339
2024
Q2
$122K Sell
18,676
-11,415
-38% -$80.7K 0.02% 289
2024
Q1
$262K Buy
30,091
+12,030
+67% +$146K 0.03% 258
2023
Q4
$207K Buy
18,061
+14,064
+352% +$139K 0.04% 202
2023
Q3
$38.5K Buy
3,997
+1,961
+96% +$19.2K 0.01% 246
2023
Q2
$21.7K Sell
2,036
-53
-3% -$570 0.01% 259
2023
Q1
$22K Buy
2,089
+531
+34% +$5.95K 0.01% 207
2022
Q4
$19.3K Buy
1,558
+123
+9% +$1.4K 0.01% 175
2022
Q3
$15K Buy
+1,435
New +$16.3K 0.01% 172

Other funds holding IRWD

China Universal Asset Management Company's IRWD Position: Q2 2026 in Review

China Universal Asset Management Company reduced its Ironwood Pharmaceuticals (IRWD) stake by 9.5% in Q2 2026, selling an estimated $10.6K and leaving 26,198 shares worth $110K. The position accounts for 0.01% of the portfolio, ranked #410.

China Universal Asset Management Company first reported a position in IRWD in Q3 2022 and has held it in 16 quarters since. The position peaked at $262K in Q1 2024. 123 funds tracked by Wall St. Rank hold IRWD as of Q2 2026.

  • China Universal Asset Management Company held 26,198 shares of Ironwood Pharmaceuticals worth $110K as of Q2 2026.
  • China Universal Asset Management Company sold 2,738 Ironwood Pharmaceuticals shares in Q2 2026, an estimated $10.6K.
  • Ironwood Pharmaceuticals made up 0.01% of China Universal Asset Management Company's portfolio in Q2 2026, its #410 holding.
  • China Universal Asset Management Company first reported a position in Ironwood Pharmaceuticals in Q3 2022 and has held it in 16 quarters since.
  • China Universal Asset Management Company's Ironwood Pharmaceuticals position peaked at $262K in Q1 2024.
  • 123 funds tracked by Wall St. Rank held Ironwood Pharmaceuticals as of Q2 2026.

Based on China Universal Asset Management Company's 13F filing for Q2 2026, filed 24 Jul 2026.